Literature DB >> 8823774

Clinical decision making in brain metastases.

E Arbit1, M Wronski.   

Abstract

Surgery for metastatic cancer of the brain parenchyma has been shown to increase length of survival, especially in patients with primary breast cancer, RCC, and lung cancer. The identification of prognostic variables common to patients with brain metastases has permitted development of therapeutic guidelines.

Entities:  

Mesh：

Year:  1996        PMID： 8823774

Source DB:  PubMed          Journal:  Neurosurg Clin N Am        ISSN： 1042-3680            Impact factor:   2.509


  9 in total

1.  Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases.

Authors:  Andreas M Stark; Kerrin Tongers; Nicolai Maass; H Maximilian Mehdorn; Janka Held-Feindt
Journal:  J Cancer Res Clin Oncol       Date:  2004-12-08       Impact factor: 4.553

2.  Stereotactic radiosurgery for brain metastases from malignant melanoma and the impact of hemorrhagic metastases.

Authors:  Kristine Bauer-Nilsen; Daniel M Trifiletti; Ajay Chatrath; Henry Ruiz-Garcia; Eduardo Marchan; Jennifer Peterson; Byron C May; Jason P Sheehan
Journal:  J Neurooncol       Date:  2018-06-20       Impact factor: 4.130

3.  Differential expression of matrix metalloproteinases in brain- and bone-seeking clones of metastatic MDA-MB-231 breast cancer cells.

Authors:  Andreas M Stark; Bartosz Anuszkiewicz; Rolf Mentlein; Toshiyuki Yoneda; H Maximilian Mehdorn; Janka Held-Feindt
Journal:  J Neurooncol       Date:  2006-07-19       Impact factor: 4.130

4.  Long-term survival with metastatic cancer to the brain.

Authors:  W A Hall; H R Djalilian; E S Nussbaum; K H Cho
Journal:  Med Oncol       Date:  2000-11       Impact factor: 3.064

5.  Surgical treatment for brain metastases: prognostic factors and survival in 177 patients.

Authors:  Andreas M Stark; Hauke Tscheslog; Ralf Buhl; Janka Held-Feindt; H Maximilian Mehdorn
Journal:  Neurosurg Rev       Date:  2004-12-18       Impact factor: 3.042

6.  Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases.

Authors:  Kyeung Min Joo; In H Park; Ji Y Shin; Juyoun Jin; Bong Gu Kang; Mi Hyun Kim; Se Jeong Lee; Mi-young Jo; Seung U Kim; Do-Hyun Nam
Journal:  Mol Ther       Date:  2009-01-06       Impact factor: 11.454

7.  Outcome of surgical resection of symptomatic cerebral lesions in non-small cell lung cancer patients with multiple brain metastases.

Authors:  Noah Hong; Heon Yoo; Ho Shin Gwak; Sang Hoon Shin; Seung Hoon Lee
Journal:  Brain Tumor Res Treat       Date:  2013-10-31

8.  Hippocampal avoidance with volumetric modulated arc therapy in melanoma brain metastases - the first Australian experience.

Authors:  Raef Awad; Gerald Fogarty; Angela Hong; Patricia Kelly; Diana Ng; Daniel Santos; Lauren Haydu
Journal:  Radiat Oncol       Date:  2013-03-18       Impact factor: 3.481

9.  The fibrinolytic system facilitates tumor cell migration across the blood-brain barrier in experimental melanoma brain metastasis.

Authors:  George Perides; Yuzheng Zhuge; Tina Lin; Monique F Stins; Roderick T Bronson; Julian K Wu
Journal:  BMC Cancer       Date:  2006-03-09       Impact factor: 4.430
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.